Multi-Bln Dollar Industry, Expanding Markets, and Strong
Partnerships Have MedMJ Giant CBIS Flying High
Summer is cruising along and you and I have seen a wide range of
big plays these recent months. One thing is for sure though, we
havent seen anything quite like the company were
profiling tonight as our focus turns to one of the leading MedMJ
companies that took the market by storm this year
to be waking up once again.
With New York State recently permitting the use of MedMJ that
makes 23 states
almost half the nation, that have gone
Regardless of your personal feeling on the matter, its not
going away. It seems MJ is here to stay and with the movement
rising rapidly its becoming impossible to ignore. So lets
get to it:
CBIS works with leading experts in drug development, medicinal
characterization and clinical research to develop, produce, and
commercialize novel therapeutic approaches for the treatment of
illnesses caused by infections as well as for age-related
illness. The Companys initial focus is on skin cancers and
Now while there may be quite a few MJ startups playing games out
there, CBIS seems to be the real deal. Just take a look at this
WSJ article Pot Industry Puts on a Tie released
earlier this month, spotlighting the Chief Financial Officer at
CBIS, Robert Kane.
Now that is about as big of a deal as
What we may be looking at is the next Boon market. Startups in
the MJ sector could soon be touting Bln Dlr IPOs and
numbers like this show why; MarijuanaIndex.org
lists over 40 publicly traded companies in the industry, with a
combined market capitalization of nearly 4Bln Dlrs.
The MJ market is quickly becoming Big Business, there is a race
happening right now to find out who ends up on top and with the
way it is looking CBIS certainly appears to hold a lot of the
cards right now.
To get an idea on just how enormous this market is and the
potential it has to transform these small market companies just
look at these figures:
government surveys, some 25M
Americans have smoked MJ in the past year, and more than 14M
Americans do so on a regular basis.
Studies have shown the MJ market could be valued at a
staggering 120 Bln Dlrs.
The public is trending towards legalization. In a Pew
Research Center poll, a majority of
Americans (52%) favored legalization, the first
time that threshold has been reached since polling began on that
issue back in 1969.
With 2.4M Med-MJ patients in the U.S. this market is
already absolutely enormous and with the direction the Country is
moving things are only getting larger.
A budget proposal from Colorado Gov. estimates MJ sales would reach approximately 610M
next fiscal year.
The market for Med MJ has exploded in recent years with many
states reporting massive growth. From a recent survey, sales from
MJ stores in the Los Angeles area alone are
estimated at 3Bln Dlrs per year, and maybe even
the size of the L.A. market alone, the national market could
reach as high as 100 Bln Dlrs.
Now in case you havent heard the news yet
New York has become the latest state to
permit the use of Med-MJ. In doing so Gov. Andrew
Cuomo has opened one of the largest marketplaces to companies
focused on medical grade MJ treatments.
To take advantage of the recent news out of New York, as well as
the social and economic trends, CBIS has laid the groundwork for
long term success.
New York legalizes medical marijuana
In addition to several recent
announcements of clinical trials and other research surrounding
their proprietary formulations of cannabinoid treatments, the
Company has also made waves with its financial postings.
In its fiscal year ending March 31st, CBIS has tripled its Total
Assets and lowered its net losses by nearly 2/3rds, all the while
raising sufficient capital to use to invest in its pre-clinical
Company has also recently signed a distribution agreement with
MDS, which is owned by Medbox Inc., that will garner the company
half the gross profits on MDS equipment sold in markets across
nearly every continent on earth. In addition, a unique
partnership with Dutch cannabis company Mediwiet will enable CBIS
to conduct one of the worlds largest observational studies
on medicinal cannabis-based medicine.
With landmark legislation opening up new, untapped markets
seemingly every month, CBIS couldnt ask for much more
so get started on researching this exciting young MedMJ
company right away.
Remember, we always encourage you to do further research. Never
take our word for it, read our disclaimer to see why, and of
course always consult a professional.
Just because a situation looks great things can still go wrong
and often do. Be smart and protect yourself.
Enjoy your evening,